BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18268189)

  • 1. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy.
    Gibbons CH; Vernino SA; Freeman R
    Arch Neurol; 2008 Feb; 65(2):213-7. PubMed ID: 18268189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody titers predict clinical features of autoimmune autonomic ganglionopathy.
    Gibbons CH; Freeman R
    Auton Neurosci; 2009 Mar; 146(1-2):8-12. PubMed ID: 19144572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy.
    Iodice V; Kimpinski K; Vernino S; Sandroni P; Fealey RD; Low PA
    Neurology; 2009 Jun; 72(23):2002-8. PubMed ID: 19506222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with rituximab of autoimmune autonomic ganglionopathy in a patient with lymphoma.
    Hollenbeck R; Black BK; Peltier AC; Biaggioni I; Robertson D; Winton EF; Raj SR
    Arch Neurol; 2011 Mar; 68(3):372-5. PubMed ID: 21059985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Problem Solving: A Tobacco Merchant Who Can't Spit.
    Benizri S; Agmon-Levin N; Kitrey ND; Carter D; Goshen E; Sharabi Y
    Isr Med Assoc J; 2017 Dec; 19(12):786-791. PubMed ID: 29235746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cardiovascular autonomic and clinical changes after immunoglobulin G immunoadsorption therapy in autoimmune autonomic ganglionopathy.
    Barbic F; Dipaola F; Andreetta F; Brunetta E; Dalla Vecchia L; Mantegazza R; Furlan R; Antozzi C
    J Hypertens; 2017 Jul; 35(7):1513-1520. PubMed ID: 28319594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune autonomic ganglionopathy with reversible cognitive impairment.
    Gibbons CH; Centi J; Vernino S; Freeman R
    Arch Neurol; 2012 Apr; 69(4):461-6. PubMed ID: 22158721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy.
    Gibbons CH; Vernino SA; Kaufmann H; Freeman R
    Neurology; 2005 Oct; 65(7):1104-6. PubMed ID: 16217067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic autoimmune autonomic ganglionopathy as the first symptom of bladder cancer: a case report and review of literature.
    de Rojas Leal C; Lage-Sánchez JM; Pinel-Ríos J; León Plaza O; Hamad-Cueto O; Dawid de Vera MT; Dawid-Milner MS
    Neurol Sci; 2022 Aug; 43(8):4841-4845. PubMed ID: 35482157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune autonomic ganglionopathy with late-onset encephalopathy.
    Baker SK; Morillo C; Vernino S
    Auton Neurosci; 2009 Mar; 146(1-2):29-32. PubMed ID: 19028442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for autoimmune autonomic ganglionopathy.
    Iodice V; Kimpinski K; Vernino S; Sandroni P; Low PA
    Auton Neurosci; 2009 Mar; 146(1-2):22-5. PubMed ID: 19056323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoimmune autonomic ganglionopathy].
    Nakane S
    Rinsho Shinkeigaku; 2019 Dec; 59(12):783-790. PubMed ID: 31761837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer.
    Peltier AC; Black BK; Raj SR; Donofrio P; Robertson D; Biaggioni I
    Muscle Nerve; 2010 Mar; 41(3):416-9. PubMed ID: 19882640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review.
    Bouxin M; Schvartz B; Mestrallet S; Debrumetz A; Hentzien M; Tabary T; Cohen R; Nicolas G; Bani-Sadr F
    J Neuroimmunol; 2019 Jan; 326():28-32. PubMed ID: 30468952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of autoimmune autonomic ganglionopathy manifesting anhidrosis.
    Yoshifuku A; Yoneda K; Sakiyama Y; Higuchi O; Nakane S; Kanekura T
    J Dermatol; 2017 Oct; 44(10):1160-1163. PubMed ID: 28620980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudomotor dysfunction in autoimmune autonomic ganglionopathy.
    Kimpinski K; Iodice V; Sandroni P; Fealey RD; Vernino S; Low PA
    Neurology; 2009 Nov; 73(18):1501-6. PubMed ID: 19884578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invited Article: Autonomic ganglia: target and novel therapeutic tool.
    Vernino S; Sandroni P; Singer W; Low PA
    Neurology; 2008 May; 70(20):1926-32. PubMed ID: 18474849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seronegative autoimmune autonomic neuropathy: a distinct clinical entity.
    Golden EP; Bryarly MA; Vernino S
    Clin Auton Res; 2018 Feb; 28(1):115-123. PubMed ID: 29280036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy.
    Koay S; Vichayanrat E; Bremner F; Panicker JN; Lang B; Lunn MP; Watson L; Ingle GT; Hagen EM; McNamara P; Jacobson L; Provitera V; Nolano M; Vincent A; Mathias CJ; Iodice V
    Ann Neurol; 2021 Apr; 89(4):753-768. PubMed ID: 33438240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy.
    Gupta A; Harris S; Vernino S; Naina HV
    Clin Auton Res; 2015 Aug; 25(4):255-8. PubMed ID: 26245264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.